QoL

You have access
Comparison of Quality of Life and Injection Site Reactions After Switching from Degarelix 80 mg to 480 mg in Advanced Prostate Cancer: A Prospective Trial
KEIICHIRO MIYAJIMA, TAKAFUMI YANAGISAWA, HIROTAKA SUZUKI, WATARU FUKUOKAYA, KEIGO SAKANAKA, KOKI OBAYASHI, JUN MIKI and TAKAHIRO KIMURA

Anticancer Research April 2023, 43 (4) 1611-1621; DOI: https://doi.org/10.21873/anticanres.16311
You have access
Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrence
HANS-CHRISTIAN KOLBERG, HELENA NIESING, JAYANT S. VAIDYA, LEYLA AKPOLAT-BASCI, ABDRHMAN MAGUZ, OLIVER HOFFMANN, GYOERGY LOEVEY, MILTIADES STEPHANOU and CORNELIA KOLBERG-LIEDTKE

Anticancer Research February 2023, 43 (2) 733-739; DOI: https://doi.org/10.21873/anticanres.16212
You have access
Interventions to Reduce Neurological Symptoms in Patients with GBM Receiving Radiotherapy: From Theory to Clinical Practice
LUCIA PALOMBI, PAOLO MARCHETTI, MAURIZIO SALVATI, MATTIA FALCHETTO OSTI, LUIGI FRATI and ALESSANDRO FRATI

Anticancer Research April 2018, 38 (4) 2423-2427;

Main menu